Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading IDRA News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.97% | 73.43 | 0.9% | $725.96m | |
| AMGN | Amgen Inc. | 0.73% | 180.48 | 1.1% | $595.28m | |
| CELG | Celgene Corporation | 1.49% | 137.01 | 1.1% | $590.43m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.75% | 520.74 | 2.7% | $544.96m | |
| BIIB | Biogen Inc. | 0.71% | 283.94 | 1.2% | $408.30m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.19% | 159.38 | 1.9% | $369.41m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.79% | 129.58 | 1.9% | $285.60m | |
| CLVS | Clovis Oncology, Inc. | 4.03% | 87.23 | 18.0% | $175.92m | |
| INCY | Incyte Corporation | 2.07% | 133.15 | 2.6% | $169.94m | |
| TSRO | TESARO, Inc. | 3.18% | 127.96 | 14.7% | $169.45m | |
| ILMN | Illumina, Inc. | -0.49% | 173.03 | 3.5% | $159.06m | |
| EXEL | Exelixis, Inc. | 1.94% | 27.27 | 6.5% | $156.33m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.63% | 87.78 | 4.4% | $131.88m | |
| KITE | Kite Pharma, Inc. | 2.87% | 108.46 | 16.1% | $123.07m | |
| BLUE | Bluebird Bio, Inc. | 0.72% | 98.00 | 19.3% | $118.15m |
Company Profile
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The company uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.